We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.34B
AUM Growth
–
Cap. Flow
+$4.36B
Cap. Flow %
81.59%
Top 10 Hldgs %
16.76%
Holding
517
New
456
Increased
–
Reduced
–
Closed
–
Avg Time Held Equity + Options
0 quarters
Top 10 Avg Time Held Equity + Options
0 quarters
Top 20 Avg Time Held Equity + Options
0 quarters
Avg Time Held Equity only
0 quarters
Top 10 Avg Time Held Equity only
0 quarters
Top 20 Avg Time Held Equity only
0 quarters

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.34%
2 Consumer Staples 15.45%
3 Real Estate 13.97%
4 Consumer Discretionary 7.8%
5 Healthcare 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HZNP
376
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$295K 0.01%
+120,000
New +$288K
2013 Q2
0 quarters
MTOR
377
DELISTED
MERITOR, Inc.
MTOR
$279K 0.01%
+39,600
New +$237K
2013 Q2
0 quarters
OIG
378
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$278K 0.01%
+1,250
New +$275K
2013 Q2
0 quarters
ANTH
379
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$278K 0.01%
+9,375
New +$350K
2013 Q2
0 quarters
ACN icon
380
PUT
Accenture
ACN
$128B
$243K ﹤0.01%
+30,000
New +$2.38M
2013 Q2
0 quarters
CMA icon
381
PUT
DELISTED
Comerica
CMA
$239K ﹤0.01%
+250,000
New +$9.33M
2013 Q2
0 quarters
CNSY icon
382
Cerenome
CNSY
$14.6M
– –
0
– –
2013 Q2
0 quarters
DD icon
383
PUT
DELISTED
Du Pont De Nemours E I
DD
$220K ﹤0.01%
+371,498
New +$18.8M
2013 Q2
0 quarters
TTPH
384
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$218K ﹤0.01%
+1,550
New +$245K
2013 Q2
0 quarters
GM icon
385
CALL
General Motors
GM
$72.6B
$212K ﹤0.01%
+10,470
New +$332K
2013 Q2
0 quarters
ESC
386
DELISTED
EMERITUS CORP
ESC
$212K ﹤0.01%
+9,133
New +$232K
2013 Q2
0 quarters
KMB icon
387
PUT
Kimberly-Clark
KMB
$32.5B
$205K ﹤0.01%
+312,900
New +$30.2M
2013 Q2
0 quarters
GDI
388
CALL
DELISTED
GARDNER DENVER,INC
GDI
$202K ﹤0.01%
+196,100
New +$14.7M
2013 Q2
0 quarters
TGT icon
389
PUT
Target
TGT
$69.8B
$187K ﹤0.01%
+103,500
New +$7.2M
2013 Q2
0 quarters
VXX icon
390
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$186K ﹤0.01%
+3,203
New +$4.01M
2013 Q2
0 quarters
FHN icon
391
CALL
First Horizon
FHN
$10.9B
$184K ﹤0.01%
+320,000
New +$3.46M
2013 Q2
0 quarters
AXP icon
392
PUT
American Express
AXP
$208B
$182K ﹤0.01%
+100,000
New +$7.11M
2013 Q2
0 quarters
JWN icon
393
PUT
DELISTED
Nordstrom
JWN
$166K ﹤0.01%
+155,900
New +$9.04M
2013 Q2
0 quarters
HOT
394
CALL
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$152K ﹤0.01%
+50,000
New +$3.25M
2013 Q2
0 quarters
MM
395
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
$147K ﹤0.01%
+16,851
New +$125K
2013 Q2
0 quarters
SHW icon
396
PUT
Sherwin-Williams
SHW
$77.5B
$146K ﹤0.01%
+79,500
New +$4.79M
2013 Q2
0 quarters
XOMA icon
397
DELISTED
Xoma
XOMA
$118K ﹤0.01%
+1,620
New +$121K
2013 Q2
0 quarters
XOP icon
398
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.96B
$107K ﹤0.01%
+40,175
New +$9.5M
2013 Q2
0 quarters
C icon
399
CALL
Citigroup
C
$217B
$106K ﹤0.01%
+200,000
New +$9.62M
2013 Q2
0 quarters
KMB icon
400
CALL
Kimberly-Clark
KMB
$32.5B
$105K ﹤0.01%
+338,975
New +$32.7M
2013 Q2
0 quarters

Similar funds

UBS O'Connor's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for UBS O'Connor, which disclosed 517 positions worth $5.34B. Its ten largest holdings account for 17% of the portfolio.

Its largest position is Pfizer: 6,269,077 shares worth $167M.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, followed by Consumer Staples and Real Estate.

  • UBS O'Connor's largest Q2 2013 buy was Pfizer: 6,269,077 shares worth $167M.
  • UBS O'Connor's ten largest holdings make up 17% of its $5.34B portfolio in Q2 2013.
  • UBS O'Connor disclosed 517 positions in Q2 2013, its first 13F filing on record.

Based on UBS O'Connor's 13F filing for Q2 2013, filed 13 Aug 2013.